Hepatitis B trials in United States
19 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluation of Patients With Liver Disease
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 8,050
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00001971 - No phaseTaking peopleHIV/HBV/HCV Triple Screening in Primary Care
- Where
- Dallas
- Age
- 18 years and over
- People
- 50
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07031219 - Phase 2Taking peopleStudy of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Where
- Baltimore, New York, Redwood City, San Antonio
- Age
- 18 years to 65 years
- People
- 70 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07654283 · EU 2025-524159-30-00 - No phaseTaking peopleBlood Collection Biorepository for Liver Disease Research
- Where
- Buffalo
- Age
- 7 years and over
- People
- 1,000
- Run by
- State University of New York at Buffalo
See details and how to joinNCT03025074 - Phase 2Taking peopleLiver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Where
- Ann Arbor, Cleveland, Durham, La Jolla, Los Angeles, Miami, New York, Richmond, Rochester, San Francisco
- Age
- 18 years to 75 years
- People
- 260
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT05832229 - Phase 4Taking peopleNational Liver Cancer Screening Trial
- Where
- Ann Arbor, Boston, Chapel Hill, Chicago, Cleveland, Dallas, Detroit, Houston, Indianapolis, Los Angeles, Manhasset, Minneapolis, Philadelphia, Redwood City, Richmond, Roseville, San Francisco
- Age
- 18 years to 85 years
- People
- 5,500
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06084234 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- Where
- Baltimore, Chandler, Huntington Beach, Iowa City, Lake Forest, Lenexa, Long Beach, Oakland, Peachtree Corners, Richmond, San Antonio, Webster
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- GigaGen, Inc.
See details and how to joinNCT07024641 - Phase 1Taking peoplePhase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
- Where
- Boston
- Age
- 18 years to 70 years
- People
- 45 worldwide
- Run by
- Precision BioSciences, Inc.
See details and how to joinNCT06680232 · EU 2025-524157-13-00 - No phaseTaking peopleRapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
- Where
- Harpers Ferry
- Age
- 18 years and over
- People
- 200
- Run by
- West Virginia University
See details and how to joinNCT07317687 - No phaseTaking peopleCollection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Where
- Coon Rapids, Dallas, Fridley, Memphis, Minneapolis, Redondo Beach, Richardson
- Age
- 18 years and over
- People
- 1,200
- Run by
- Helio Genomics
See details and how to joinNCT05181826 - Phase 3Not yet taking people in United StatesDuo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
- Where
- Los Angeles, The Bronx
- Age
- 18 years to 29 years
- People
- 400 worldwide
- Run by
- HIV Prevention Trials Network
See details and how to joinNCT07658976 - No phaseTaking peopleAdaptability of an Undetectable = Untransmissible Model for HBV
- Where
- New York
- Age
- 18 years to 65 years
- People
- 55
- Run by
- NYU Langone Health
See details and how to joinNCT07449091 - No phaseEnrolling by invitationA Long-term Observational Study in Participants Who Have Received PBGENE-HBV
- Where
- Boston
- Age
- 19 years to 80 years
- People
- 45 worldwide
- Run by
- Precision BioSciences, Inc.
See details and how to joinNCT07254208 - Phase 1Taking peopleTLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- Where
- Baltimore
- Age
- 18 years and over
- People
- 10
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT04843852 - Phase 2Taking peopleIntrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
- Where
- Baltimore
- Age
- 18 years and over
- People
- 10
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT06154278 - No phaseTaking peopleAntiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
- Where
- Wilmington
- Age
- 12 years to 60 years
- People
- 24,258
- Run by
- Syneos Health
See details and how to joinNCT00404989 - Phase 1/2Taking peopleA Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
- Where
- New York
- Age
- 18 years to 70 years
- People
- 46 worldwide
- Run by
- SCG Cell Therapy Pte. Ltd.
See details and how to joinNCT05417932 - No phaseTaking peopleLong-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
- Where
- Hillsborough, Miami, San Diego
- Age
- 20 years to 70 years
- People
- 50 worldwide
- Run by
- Arbutus Biopharma Corporation
See details and how to joinNCT06277037 - Phase 4Taking peopleComparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
- Where
- Baltimore
- Age
- 18 years and over
- People
- 200
- Run by
- Mercy Medical Center
See details and how to joinNCT04588077